Kiniksa Pharmaceuticals International, plc

NasdaqGS:KNSA Stock Report

Market Cap: US$1.5b

Kiniksa Pharmaceuticals International, plc Company Information

Kiniksa Pharmaceuticals International, plc's employee growth, exchange listings and data sources


Key Information

  • Name: Kiniksa Pharmaceuticals International, plc
  • Ticker: KNSA
  • Exchange: NasdaqGS
  • Founded: 2015
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$1.531b
  • Shares Outstanding: 72.20m
  • Website: https://www.kiniksa.com

Number of Employees


Location

  • Kiniksa Pharmaceuticals International, plc
  • 23 Old Bond Street
  • Floor 3
  • London
  • Greater London
  • WIS 4PZ
  • United Kingdom


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
KNSANasdaqGS (Nasdaq Global Select)YesClass A Common SharesUSUSDMay 2018

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/21 23:24
End of Day Share Price 2024/11/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.